These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 22570295)

  • 1. Total dose iron dextran infusion in cancer patients: is it SaFe2+?
    Gilreath JA; Stenehjem DD; Rodgers GM
    J Natl Compr Canc Netw; 2012 May; 10(5):669-76. PubMed ID: 22570295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies.
    Sloand JA; Shelly MA; Erenstone AL; Schiff MJ; Talley TE; Dhakal MP
    Perit Dial Int; 1998; 18(5):522-7. PubMed ID: 9848632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intravenous iron sucrose versus low-molecular-weight iron dextran in chronic kidney disease.
    Sinha S; Chiu DY; Peebles G; Kolakkat S; Lamerton E; Fenwick S; Kalra PA
    J Ren Care; 2009 Jun; 35(2):67-73. PubMed ID: 19432851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary edema: atypical anaphylactoid reaction to intravenous iron dextran.
    Freter S; Davidman M; Lipman M; Bercovitch D
    Am J Nephrol; 1997; 17(5):477-9. PubMed ID: 9382172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of total dose infusion of iron dextran in iron deficiency anaemia.
    Reddy CM; Kathula SK; Ali SA; Bekal R; Walsh M
    Int J Clin Pract; 2008 Mar; 62(3):413-5. PubMed ID: 18005041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute injury with intravenous iron and concerns regarding long-term safety.
    Bishu K; Agarwal R
    Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S19-23. PubMed ID: 17699372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease.
    Koutroubakis IE; Oustamanolakis P; Karakoidas C; Mantzaris GJ; Kouroumalis EA
    Dig Dis Sci; 2010 Aug; 55(8):2327-31. PubMed ID: 19834803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of total dose iron dextran infusion in geriatric patients with chronic kidney disease and iron deficiency anemia.
    Dossabhoy NR; Turley S; Gascoyne R; Tapolyai M; Sulaiman K
    Ren Fail; 2014 Aug; 36(7):1033-7. PubMed ID: 24845687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease.
    Mamula P; Piccoli DA; Peck SN; Markowitz JE; Baldassano RN
    J Pediatr Gastroenterol Nutr; 2002 Mar; 34(3):286-90. PubMed ID: 11964953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reticulocyte hemoglobin content predicts functional iron deficiency in hemodialysis patients receiving rHuEPO.
    Mittman N; Sreedhara R; Mushnick R; Chattopadhyay J; Zelmanovic D; Vaseghi M; Avram MM
    Am J Kidney Dis; 1997 Dec; 30(6):912-22. PubMed ID: 9398141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accelerated total dose infusion of low molecular weight iron dextran is safe and efficacious in chronic kidney disease patients.
    Sinha S; Chiu D; Peebles G; Swoboda P; Kolakkat S; Lamerton E; Fenwick S; Bhandari S; Kalra PA
    QJM; 2011 Mar; 104(3):221-30. PubMed ID: 20956457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of total dose infusion of low molecular weight iron dextran in the treatment of iron deficiency anemia during pregnancy.
    Ayub R; Tariq N; Adil MM; Iqbal M; Junaid A; Jaferry T
    J Coll Physicians Surg Pak; 2008 Jul; 18(7):424-7. PubMed ID: 18760066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative rates of adverse events with different formulations of intravenous iron.
    Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
    Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous iron dextran therapy in patients with iron deficiency and normal renal function who failed to respond to or did not tolerate oral iron supplementation.
    Barton JC; Barton EH; Bertoli LF; Gothard CH; Sherrer JS
    Am J Med; 2000 Jul; 109(1):27-32. PubMed ID: 10936475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of iron sucrose in patients sensitive to iron dextran: North American clinical trial.
    Van Wyck DB; Cavallo G; Spinowitz BS; Adhikarla R; Gagnon S; Charytan C; Levin N
    Am J Kidney Dis; 2000 Jul; 36(1):88-97. PubMed ID: 10873877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron Treatment Strategies in Dialysis-Dependent CKD.
    Pandey R; Daloul R; Coyne DW
    Semin Nephrol; 2016 Mar; 36(2):105-11. PubMed ID: 27236131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How we diagnose and treat iron deficiency anemia.
    Auerbach M; Adamson JW
    Am J Hematol; 2016 Jan; 91(1):31-8. PubMed ID: 26408108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron.
    Plummer ES; Crary SE; McCavit TL; Buchanan GR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1747-52. PubMed ID: 23832487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse events in chronic hemodialysis patients receiving intravenous iron dextran--a comparison of two products.
    McCarthy JT; Regnier CE; Loebertmann CL; Bergstralh EJ
    Am J Nephrol; 2000; 20(6):455-62. PubMed ID: 11146312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of iron deficiency by a bolus intravenous iron dextran in peritoneal dialysis].
    Ficheux M; Cuny P; Lecouf A; Ryckelynck JP; Hurault de Ligny B; Lobbedez T
    Nephrol Ther; 2011 Dec; 7(7):558-61. PubMed ID: 21715234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.